(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ Composite: ARCT) dropped 6.26% to $36.23 at 16:55 EST on Tuesday, following the last session’s upward trend. NASDAQ Composite is falling 0.6% to $15,886.54, after five sequential sessions in a row of gains. This seems, at the moment, a somewhat down trend trading session today.

Arcturus Therapeutics’s last close was $38.65, 70.2% under its 52-week high of $129.71.


Today’s last reported volume for Arcturus Therapeutics is 1099334 which is 76.13% above its average volume of 624132.

Arcturus Therapeutics’s Sales

Arcturus Therapeutics’s sales growth is 625.3% for the ongoing quarter and 1814.2% for the next. The company’s growth estimates for the ongoing quarter is a negative 72.8% and positive 6.4% for the next.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.


Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a negative 7.91%, a negative 0.55%, and a positive 3.74%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.91% (last week), 3.24% (last month), and 3.74% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be overbought (>=80).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $36.23 at 16:55 EST, way below its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s value is way under its 50-day moving average of $45.68 and way under its 200-day moving average of $40.36.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here